This chapter explores the problem of drug shortages in the US and discusses efforts to address it, including legislation, economic incentives, and quality assessment.
Bloomberg’s Ike Swetlitz and Riley Griffin join this episode to discuss what’s driving the shortage of generic drugs in the US, including amoxicillin, and what can be done to restore supplies.